481 related articles for article (PubMed ID: 6391781)
1. Clinical pharmacokinetics of the antituberculosis drugs.
Holdiness MR
Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
[TBL] [Abstract][Full Text] [Related]
2. Neurological manifestations and toxicities of the antituberculosis drugs. A review.
Holdiness MR
Med Toxicol; 1987; 2(1):33-51. PubMed ID: 3547005
[TBL] [Abstract][Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of rifampicin.
Acocella G
Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
van Oosterhout JJ; Dzinjalamala FK; Dimba A; Waterhouse D; Davies G; Zijlstra EE; Molyneux ME; Molyneux EM; Ward S
Antimicrob Agents Chemother; 2015 Oct; 59(10):6175-80. PubMed ID: 26248378
[TBL] [Abstract][Full Text] [Related]
7. The binding of antituberculous drugs to normal and kwashiorkor serum.
Buchanan N; van der Walt LA
S Afr Med J; 1977 Sep; 52(13):522-5. PubMed ID: 918794
[TBL] [Abstract][Full Text] [Related]
8. Chromatographic analysis of antituberculosis drugs in biological samples.
Holdiness MR
J Chromatogr; 1985 May; 340():321-59. PubMed ID: 2410437
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring in the treatment of tuberculosis.
Peloquin CA
Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of isoniazid.
Weber WW; Hein DW
Clin Pharmacokinet; 1979; 4(6):401-22. PubMed ID: 391461
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Mlotha R; Waterhouse D; Dzinjalamala F; Ardrey A; Molyneux E; Davies GR; Ward S
J Antimicrob Chemother; 2015; 70(6):1798-803. PubMed ID: 25759035
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
13. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India.
Aruldhas BW; Hoglund RM; Ranjalkar J; Tarning J; Mathew SK; Verghese VP; Bose A; Mathew BS
Br J Clin Pharmacol; 2019 Mar; 85(3):644-654. PubMed ID: 30588647
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
15. Does AIDS impair the absorption of antituberculosis agents?
Taylor B; Smith PJ
Int J Tuberc Lung Dis; 1998 Aug; 2(8):670-5. PubMed ID: 9712282
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic drug monitoring of antituberculosis drugs].
Goromaru T
Nihon Rinsho; 1990 Feb; 48 Suppl():1226-8. PubMed ID: 2355527
[No Abstract] [Full Text] [Related]
17. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of tuberculous meningitis in children and adults.
Donald PR
Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
Gurumurthy P; Ramachandran G; Vijayalakshmi S; Kumar AK; Venkatesan P; Chandrasekaran V; Vjayasekaran V; Kumaraswami V; Prabhakar R
Int J Tuberc Lung Dis; 1999 Feb; 3(2):119-25. PubMed ID: 10091876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
